<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37108151</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>10</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Rapid and Robust Multi-Phenotypic Assay System for ALS Using Human iPS Cells with Mutations in Causative Genes.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">6987</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24086987</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a major life-threatening disease caused by motor neuron degeneration. More effective treatments through drug discovery are urgently needed. Here, we established an effective high-throughput screening system using induced pluripotent stem cells (iPSCs). Using a Tet-On-dependent transcription factor expression system carried on the <i>PiggyBac</i> vector, motor neurons were efficiently and rapidly generated from iPSCs by a single-step induction method. Induced iPSC transcripts displayed characteristics similar to those of spinal cord neurons. iPSC-generated motor neurons carried a mutation in <i>fused in sarcoma</i> (<i>FUS</i>) and <i>superoxide dismutase 1</i> (<i>SOD1</i>) genes and had abnormal protein accumulation corresponding to each mutation. Calcium imaging and multiple electrode array (MEA) recordings demonstrated that ALS neurons were abnormally hyperexcitable. Noticeably, protein accumulation and hyperexcitability were ameliorated by treatment with rapamycin (mTOR inhibitor) and retigabine (Kv7 channel activator), respectively. Furthermore, rapamycin suppressed ALS neuronal death and hyperexcitability, suggesting that protein aggregate clearance through the activation of autophagy effectively normalized activity and improved neuronal survival. Our culture system reproduced several ALS phenotypes, including protein accumulation, hyperexcitability, and neuronal death. This rapid and robust phenotypic screening system will likely facilitate the discovery of novel ALS therapeutics and stratified and personalized medicine for sporadic motor neuron diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kondo</LastName><ForeName>Tosho</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-6236-3489</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center of Neurology, Ono Pharmaceutical Co., Ltd., Osaka 618-8585, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebinuma</LastName><ForeName>Ihori</ForeName><Initials>I</Initials><Identifier Source="ORCID">0009-0004-0505-8815</Identifier><AffiliationInfo><Affiliation>Research Center of Neurology, Ono Pharmaceutical Co., Ltd., Osaka 618-8585, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Hirotaka</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center of Neurology, Ono Pharmaceutical Co., Ltd., Osaka 618-8585, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishikawa</LastName><ForeName>Yukitoshi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Research Center of Neurology, Ono Pharmaceutical Co., Ltd., Osaka 618-8585, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komiya</LastName><ForeName>Takaki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Research Center of Neurology, Ono Pharmaceutical Co., Ltd., Osaka 618-8585, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishikawa</LastName><ForeName>Mitsuru</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0000-9895-7238</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Regenerative Medicine, Fujita Health University School of Medicine, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake 470-1192, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okano</LastName><ForeName>Hideyuki</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-7482-5935</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Center for Brain Science, Fujita Health University, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake 470-1192, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>JP22bm0804003</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>JP22bm0804023</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>JP17K10083</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country/></Grant><Grant><GrantID>JP20H03567</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country/></Grant><Grant><GrantID>JP22K18388</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">degenerative motor neuron diseases</Keyword><Keyword MajorTopicYN="N">hyperexcitation</Keyword><Keyword MajorTopicYN="N">induced pluripotent stem cells (iPSCs)</Keyword><Keyword MajorTopicYN="N">motor neurons</Keyword><Keyword MajorTopicYN="N">protein accumulation</Keyword></KeywordList><CoiStatement>H.O. is a founding scientist and scientific advisor of SanBio Co. Ltd., and K Pharma Inc. T. Kondo, I.E., H.T., Y.N. and T. Komiya are employed by Ono Pharmaceutical Co., Ltd. H.O. received research funding from Ono Pharmaceutical Co., Ltd. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. The other authors indicate no potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>1</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37108151</ArticleId><ArticleId IdType="pmc">PMC10138792</ArticleId><ArticleId IdType="doi">10.3390/ijms24086987</ArticleId><ArticleId IdType="pii">ijms24086987</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Okano H., Morimoto S. IPSC-Based Disease Modeling and Drug Discovery in Cardinal Neurodegenerative Disorders. Cell Stem Cell. 2022;29:189&#x2013;208. doi: 10.1016/j.stem.2022.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2022.01.007</ArticleId><ArticleId IdType="pubmed">35120619</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguori F., Amadio S., Volont&#xe9; C. Where and Why Modeling Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2021;22:3977. doi: 10.3390/ijms22083977.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22083977</ArticleId><ArticleId IdType="pmc">PMC8070525</ArticleId><ArticleId IdType="pubmed">33921446</ArticleId></ArticleIdList></Reference><Reference><Citation>Du H., Huo Z., Chen Y., Zhao Z., Meng F., Wang X., Liu S., Zhang H., Zhou F., Liu J., et al. Induced Pluripotent Stem Cells and Their Applications in Amyotrophic Lateral Sclerosis. Cells. 2023;12:971. doi: 10.3390/cells12060971.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12060971</ArticleId><ArticleId IdType="pmc">PMC10047679</ArticleId><ArticleId IdType="pubmed">36980310</ArticleId></ArticleIdList></Reference><Reference><Citation>Ideno H., Imaizumi K., Shimada H., Sanosaka T., Nemoto A., Kohyama J., Okano H. Human PSCs Determine the Competency of Cerebral Organoid Differentiation via FGF Signaling and Epigenetic Mechanisms. iScience. 2022;25:105140. doi: 10.1016/j.isci.2022.105140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.105140</ArticleId><ArticleId IdType="pmc">PMC9523398</ArticleId><ArticleId IdType="pubmed">36185382</ArticleId></ArticleIdList></Reference><Reference><Citation>Imaizumi K., Okano H. Modeling Neurodevelopment in a Dish with Pluripotent Stem Cells. Dev. Growth Differ. 2021;63:18&#x2013;25. doi: 10.1111/dgd.12699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dgd.12699</ArticleId><ArticleId IdType="pmc">PMC7984205</ArticleId><ArticleId IdType="pubmed">33141454</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahromi M.A.M., Abdoli A., Rahmanian M., Bardania H., Bayandori M., Basri S.M.M., Kalbasi A., Aref A.R., Karimi M., Hamblin M.R. Microfluidic Brain-on-a-Chip: Perspectives for Mimicking Neural System Disorders. Mol. Neurobiol. 2019;56:8489&#x2013;8512. doi: 10.1007/s12035-019-01653-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-01653-2</ArticleId><ArticleId IdType="pmc">PMC6842047</ArticleId><ArticleId IdType="pubmed">31264092</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers S.M., Fasano C.A., Papapetrou E.P., Tomishima M., Sadelain M., Studer L. Highly Efficient Neural Conversion of Human ES and IPS Cells by Dual Inhibition of SMAD Signaling. Nat. Biotechnol. 2009;27:275&#x2013;280. doi: 10.1038/nbt.1529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1529</ArticleId><ArticleId IdType="pmc">PMC2756723</ArticleId><ArticleId IdType="pubmed">19252484</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiecker C., Lumsden A. The Role of Organizers in Patterning the Nervous System. Annu. Rev. Neurosci. 2012;35:347&#x2013;367. doi: 10.1146/annurev-neuro-062111-150543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-neuro-062111-150543</ArticleId><ArticleId IdType="pubmed">22462542</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkeby A., Grealish S., Wolf D.A., Nelander J., Wood J., Lundblad M., Lindvall O., Parmar M. Generation of Regionally Specified Neural Progenitors and Functional Neurons from Human Embryonic Stem Cells under Defined Conditions. Cell Rep. 2012;1:703&#x2013;714. doi: 10.1016/j.celrep.2012.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.04.009</ArticleId><ArticleId IdType="pubmed">22813745</ArticleId></ArticleIdList></Reference><Reference><Citation>Moya N., Cutts J., Gaasterland T., Willert K., Brafman D.A. Endogenous WNT Signaling Regulates HPSC-Derived Neural Progenitor Cell Heterogeneity and Specifies Their Regional Identity. Stem Cell Rep. 2014;3:1015&#x2013;1028. doi: 10.1016/j.stemcr.2014.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2014.10.004</ArticleId><ArticleId IdType="pmc">PMC4264562</ArticleId><ArticleId IdType="pubmed">25458891</ArticleId></ArticleIdList></Reference><Reference><Citation>Imaizumi K., Sone T., Ibata K., Fujimori K., Yuzaki M., Akamatsu W., Okano H. Controlling the Regional Identity of HPSC-Derived Neurons to Uncover Neuronal Subtype Specificity of Neurological Disease Phenotypes. Stem Cell Rep. 2015;5:1010&#x2013;1022. doi: 10.1016/j.stemcr.2015.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2015.10.005</ArticleId><ArticleId IdType="pmc">PMC4682123</ArticleId><ArticleId IdType="pubmed">26549851</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichiyanagi N., Fujimori K., Yano M., Ishihara-Fujisaki C., Sone T., Akiyama T., Okada Y., Akamatsu W., Matsumoto T., Ishikawa M., et al. Establishment of in Vitro FUS-Associated Familial Amyotrophic Lateral Sclerosis Model Using Human Induced Pluripotent Stem Cells. Stem Cell Rep. 2016;6:496&#x2013;510. doi: 10.1016/j.stemcr.2016.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2016.02.011</ArticleId><ArticleId IdType="pmc">PMC4834049</ArticleId><ArticleId IdType="pubmed">26997647</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainger B.J., Kiskinis E., Mellin C., Wiskow O., Han S.S.W., Sandoe J., Perez N.P., Williams L.A., Lee S., Boulting G., et al. Intrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor Neurons. Cell Rep. 2014;7:1&#x2013;11. doi: 10.1016/j.celrep.2014.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.03.019</ArticleId><ArticleId IdType="pmc">PMC4023477</ArticleId><ArticleId IdType="pubmed">24703839</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo T., Imamura K., Funayama M., Tsukita K., Miyake M., Ohta A., Woltjen K., Nakagawa M., Asada T., Arai T., et al. IPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-Amyloid &#x3b2; Combination for Alzheimer&#x2019;s Disease. Cell Rep. 2017;21:2304&#x2013;2312. doi: 10.1016/j.celrep.2017.10.109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.10.109</ArticleId><ArticleId IdType="pubmed">29166618</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi A., Ishikawa K.I., Inoshita T., Shiba-Fukushima K., Saiki S., Hatano T., Mori A., Oji Y., Okuzumi A., Li Y., et al. Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease. Stem Cell Rep. 2020;14:1060&#x2013;1075. doi: 10.1016/j.stemcr.2020.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2020.04.011</ArticleId><ArticleId IdType="pmc">PMC7355139</ArticleId><ArticleId IdType="pubmed">32470327</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniou N., Prodromidou K., Kouroupi G., Boumpoureka I., Samiotaki M., Panayotou G., Xilouri M., Kloukina I., Stefanis L., Grailhe R., et al. High Content Screening and Proteomic Analysis Identify a Kinase Inhibitor That Rescues Pathological Phenotypes in a Patient-Derived Model of Parkinson&#x2019;s Disease. NPJ Park. Dis. 2022;8:15. doi: 10.1038/s41531-022-00278-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-022-00278-y</ArticleId><ArticleId IdType="pmc">PMC8837749</ArticleId><ArticleId IdType="pubmed">35149677</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K., Ishikawa M., Otomo A., Atsuta N., Nakamura R., Akiyama T., Hadano S., Aoki M., Saya H., Sobue G., et al. Modeling Sporadic ALS in IPSC-Derived Motor Neurons Identifies a Potential Therapeutic Agent. Nat. Med. 2018;24:1579&#x2013;1589. doi: 10.1038/s41591-018-0140-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0140-5</ArticleId><ArticleId IdType="pubmed">30127392</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Pak C.H., Han Y., Ahlenius H., Zhang Z., Chanda S., Marro S., Patzke C., Acuna C., Covy J., et al. Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem Cells. Neuron. 2013;78:785&#x2013;798. doi: 10.1016/j.neuron.2013.05.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.05.029</ArticleId><ArticleId IdType="pmc">PMC3751803</ArticleId><ArticleId IdType="pubmed">23764284</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzoni E.O., Mahony S., Closser M., Morrison C.A., Nedelec S., Williams D.J., An D., Gifford D.K., Wichterle H. Synergistic Binding of Transcription Factors to Cell-Specific Enhancers Programs Motor Neuron Identity. Nat. Neurosci. 2013;16:1219&#x2013;1227. doi: 10.1038/nn.3467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3467</ArticleId><ArticleId IdType="pmc">PMC3820498</ArticleId><ArticleId IdType="pubmed">23872598</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura K., Izumi Y., Watanabe A., Tsukita K., Woltjen K., Yamamoto T., Hotta A., Kondo T., Kitaoka S., Ohta A., et al. The Src/c-Abl Pathway Is a Potential Therapeutic Target in Amyotrophic Lateral Sclerosis. Sci. Transl. Med. 2017;9:391. doi: 10.1126/scitranslmed.aaf3962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf3962</ArticleId><ArticleId IdType="pubmed">28539470</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Lin S., Staats K.A., Li Y., Chang W.H., Hung S.T., Hendricks E., Linares G.R., Wang Y., Son E.Y., et al. Haploinsufficiency Leads to Neurodegeneration in C9ORF72 ALS/FTD Human Induced Motor Neurons. Nat. Med. 2018;24:313&#x2013;325. doi: 10.1038/nm.4490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4490</ArticleId><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessell T.M. Neuronal specification in the spinal cord: Inductive signals and transcriptional codes. Nat. Rev. Genet. 2000;1:20&#x2013;29. doi: 10.1038/35049541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35049541</ArticleId><ArticleId IdType="pubmed">11262869</ArticleId></ArticleIdList></Reference><Reference><Citation>Okita K., Matsumura Y., Sato Y., Okada A., Morizane A., Okamoto S., Hong H., Nakagawa M., Tanabe K., Tezuka K.I., et al. A More Efficient Method to Generate Integration-Free Human IPS Cells. Nat. Methods. 2011;8:409&#x2013;412. doi: 10.1038/nmeth.1591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1591</ArticleId><ArticleId IdType="pubmed">21460823</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa M., Aoyama T., Shibata S., Sone T., Miyoshi H., Watanabe H., Nakamura M., Morota S., Uchino H., Yoo A.S., et al. MiRNA-Based Rapid Differentiation of Purified Neurons from HPSCs Advancestowards Quick Screening for Neuronal Disease Phenotypes In Vitro. Cells. 2020;9:532. doi: 10.3390/cells9030532.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9030532</ArticleId><ArticleId IdType="pmc">PMC7140514</ArticleId><ArticleId IdType="pubmed">32106535</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeisel A., Hochgerner H., L&#xf6;nnerberg P., Johnsson A., Memic F., van der Zwan J., H&#xe4;ring M., Braun E., Borm L.E., La Manno G., et al. Molecular Architecture of the Mouse Nervous System. Cell. 2018;174:999&#x2013;1014.e22. doi: 10.1016/j.cell.2018.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.06.021</ArticleId><ArticleId IdType="pmc">PMC6086934</ArticleId><ArticleId IdType="pubmed">30096314</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho R., Workman M.J., Mathkar P., Wu K., Kim K.J., O&#x2019;Rourke J.G., Kellogg M., Montel V., Banuelos M.G., Arogundade O.A., et al. Cross-Comparison of Human IPSC Motor Neuron Models of Familial and Sporadic ALS Reveals Early and Convergent Transcriptomic Disease Signatures. Cell Syst. 2021;12:159&#x2013;175.e9. doi: 10.1016/j.cels.2020.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2020.10.010</ArticleId><ArticleId IdType="pmc">PMC7897311</ArticleId><ArticleId IdType="pubmed">33382996</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal J., Kuang L., Barnett K.R., Zhu B.Z., Shissler S.C., Korotkov K.V., Hayward L.J., Kasarskis E.J., Zhu H. ALS Mutant SOD1 Interacts with G3BP1 and Affects Stress Granule Dynamics. Acta Neuropathol. 2016;132:563&#x2013;576. doi: 10.1007/s00401-016-1601-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1601-x</ArticleId><ArticleId IdType="pmc">PMC5023729</ArticleId><ArticleId IdType="pubmed">27481264</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrone L., Poser I., Casci I., Japtok J., Reinhardt P., Janosch A., Andree C., Lee H.O., Moebius C., Koerner E., et al. Isogenic FUS-EGFP IPSC Reporter Lines Enable Quantification of FUS Stress Granule Pathology That Is Rescued by Drugs Inducing Autophagy. Stem Cell Rep. 2018;10:375&#x2013;389. doi: 10.1016/j.stemcr.2017.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.12.018</ArticleId><ArticleId IdType="pmc">PMC5857889</ArticleId><ArticleId IdType="pubmed">29358088</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva M.C., Nandi G.A., Tentarelli S., Gurrell I.K., Jamier T., Lucente D., Dickerson B.C., Brown D.G., Brandon N.J., Haggarty S.J. Prolonged Tau Clearance and Stress Vulnerability Rescue by Pharmacological Activation of Autophagy in Tauopathy Neurons. Nat. Commun. 2020;11:3258. doi: 10.1038/s41467-020-16984-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-16984-1</ArticleId><ArticleId IdType="pmc">PMC7320012</ArticleId><ArticleId IdType="pubmed">32591533</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada S.J., Serio A., Arjun A., Bilican B., Daub A., Ando D.M., Tsvetkov A., Pleiss M., Li X., Peisach D., et al. Autophagy Induction Enhances TDP43 Turnover and Survival in Neuronal ALS Models. Nat. Chem. Biol. 2014;10:677&#x2013;685. doi: 10.1038/nchembio.1563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.1563</ArticleId><ArticleId IdType="pmc">PMC4106236</ArticleId><ArticleId IdType="pubmed">24974230</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainger B.J., Macklin E.A., Vucic S., McIlduff C.E., Paganoni S., Maragakis N.J., Bedlack R., Goyal N.A., Rutkove S.B., Lange D.J., et al. Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial. JAMA Neurol. 2021;78:186&#x2013;196. doi: 10.1001/jamaneurol.2020.4300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.4300</ArticleId><ArticleId IdType="pmc">PMC7684515</ArticleId><ArticleId IdType="pubmed">33226425</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimoto S., Takahashi S., Ito D., Okada K., Muh Chyi C., Nishiyama A., Fujimori K., Takao M., Hirai M., Kabe Y., et al. Ropinirole Hydrochloride for Amyotrophic Lateral Sclerosis: A Single-Center, Randomized 1 Feasibility, Double-Blind, Placebo-Controlled Trial. medRxiv. 2021 doi: 10.1101/2021.12.05.21267266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.12.05.21267266</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawrot J., Imhof S., Wainger B.J. Modeling Cell-Autonomous Motor Neuron Phenotypes in ALS Using IPSCs. Neurobiol. Dis. 2020;134:104680. doi: 10.1016/j.nbd.2019.104680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104680</ArticleId><ArticleId IdType="pmc">PMC7002167</ArticleId><ArticleId IdType="pubmed">31759135</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehler M.D., Wheeler B.C., Brewer G.J. Added Astroglia Promote Greater Synapse Density and Higher Activity in Neuronal Networks. Neuron Glia Biol. 2007;3:127&#x2013;140. doi: 10.1017/S1740925X07000440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1740925X07000440</ArticleId><ArticleId IdType="pmc">PMC2267743</ArticleId><ArticleId IdType="pubmed">18345351</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii T., Ishikawa M., Fujimori K., Maeda T., Kushima I., Arioka Y., Mori D., Nakatake Y., Yamagata B., Nio S., et al. In Vitro Modeling of the Bipolar Disorder and Schizophrenia Using Patient-Derived Induced Pluripotent Stem Cells with Copy Number Variations of PCDH15 and RELN. eNeuro. 2019;6:403&#x2013;418. doi: 10.1523/ENEURO.0403-18.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/ENEURO.0403-18.2019</ArticleId><ArticleId IdType="pmc">PMC6800292</ArticleId><ArticleId IdType="pubmed">31540999</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>